DRRX
USDDURECT Corporation Common Stock
$0.670-0.040 (-5.690%)
Real-time Price
Healthcare
Drug Manufacturers - Specialty & Generic
United States
Price Chart
Key Metrics
Market Metrics
Open
$0.710
High
$0.720
Low
$0.632
Volume
0.01M
Company Fundamentals
Market Cap
21.7M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.05M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.63Current $0.670High $1.88
Related News
Analyst Upgrades
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
HC Wainwright & Co. analyst Ed Arce reiterates Durect from Neutral to Neutral.
View more
PR Newswire
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided a...
View more
PR Newswire
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated ...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.